Literature DB >> 30270426

Transporters in Drug Development: Scientific and Regulatory Considerations.

Lei Zhang1, Shiew-Mei Huang1, Kellie Reynolds1, Rajanikanth Madabushi1, Issam Zineh1.   

Abstract

Transporters can affect a drug's pharmacokinetics (PK) by controlling absorption, distribution, and elimination processes. They can also affect a drug's pharmacodynamics (PD) by influencing its access to the site of action. More recently, transporters have become important as drug targets (e.g., urate transporter inhibitors as treatment for gout and sodium/glucose cotransporter-2 inhibitors for treating type 2 diabetes). As such, it is important to consider the role of transporters during drug development.
© 2018 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30270426     DOI: 10.1002/cpt.1214

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

Review 1.  Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.

Authors:  Kit Wun Kathy Cheung; Bianca D van Groen; Gilbert J Burckart; Lei Zhang; Saskia N de Wildt; Shiew-Mei Huang
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

Review 2.  Emerging Role of Organ-on-a-Chip Technologies in Quantitative Clinical Pharmacology Evaluation.

Authors:  Nina Isoherranen; Rajanikanth Madabushi; Shiew-Mei Huang
Journal:  Clin Transl Sci       Date:  2019-03       Impact factor: 4.689

3.  Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3.

Authors:  Ling Zou; Pär Matsson; Adrian Stecula; Huy X Ngo; Arik A Zur; Kathleen M Giacomini
Journal:  J Pharm Sci       Date:  2020-09-07       Impact factor: 3.784

Review 4.  Physiologically-Based Pharmacokinetic Models for Evaluating Membrane Transporter Mediated Drug-Drug Interactions: Current Capabilities, Case Studies, Future Opportunities, and Recommendations.

Authors:  Kunal S Taskar; Venkatesh Pilla Reddy; Howard Burt; Maria M Posada; Manthena Varma; Ming Zheng; Mohammed Ullah; Arian Emami Riedmaier; Ken-Ichi Umehara; Jan Snoeys; Masanori Nakakariya; Xiaoyan Chu; Maud Beneton; Yuan Chen; Felix Huth; Rangaraj Narayanan; Dwaipayan Mukherjee; Vaishali Dixit; Yuichi Sugiyama; Sibylle Neuhoff
Journal:  Clin Pharmacol Ther       Date:  2019-12-31       Impact factor: 6.875

5.  Ethnogeographic and inter-individual variability of human ABC transporters.

Authors:  Qingyang Xiao; Yitian Zhou; Volker M Lauschke
Journal:  Hum Genet       Date:  2020-03-23       Impact factor: 4.132

Review 6.  Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development.

Authors:  Kefei Wang; Kun Jiang; Xiaoyi Wei; Yulan Li; Tiejie Wang; Yang Song
Journal:  AAPS PharmSciTech       Date:  2021-07-26       Impact factor: 3.246

7.  Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia.

Authors:  Hao-Lu Sun; Yi-Wan Wu; He-Ge Bian; Hui Yang; Heng Wang; Xiao-Ming Meng; Juan Jin
Journal:  Front Pharmacol       Date:  2021-07-14       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.